Denis Chem Lab [DENISCHEM] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Denis Chem Lab Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Denis Chem Lab Ltd. wins in 9 metrics, Sun Pharmaceutical Industries Ltd. wins in 10 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Denis Chem Lab Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 12.26 36.73 Denis Chem Lab Ltd.
Price-to-Book Ratio 1.22 5.15 Denis Chem Lab Ltd.
Debt-to-Equity Ratio 0.09 6.68 Denis Chem Lab Ltd.
PEG Ratio 0.14 3.59 Denis Chem Lab Ltd.
EV/EBITDA 5.61 23.61 Denis Chem Lab Ltd.
Profit Margin (TTM) 43.34% 19.21% Denis Chem Lab Ltd.
Operating Margin (TTM) 6.45% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 6.45% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 9.49% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 7.19% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $44.64M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 4.03% 0.97% Denis Chem Lab Ltd.
1-Year Return -29.77% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 0.62 7.05 Denis Chem Lab Ltd.
Enterprise Value $1.07B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 0.62 6.66 Denis Chem Lab Ltd.
Gross Profit Margin (TTM) 49.30% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $125 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $6.28 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) N/A 0.11 N/A

Denis Chem Lab Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

DENISCHEM
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Denis Chem Lab Ltd.1.96%-4.77%-9.16%-6.26%-17.73%-12.08%
Sun Pharmaceutical Industries Ltd.-0.47%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Denis Chem Lab Ltd.-29.77%-5.54%9.45%-14.17%216.15%216.15%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Denis Chem Lab Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricDENISCHEMSUNPHARMA
Market Information
Market Cap i₹1.07B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i4,7443,903,142
90 Day Avg. Volume i9,9893,253,866
Last Close₹71.32₹1,780.10
52 Week Range₹56.10 - ₹109.25₹1,548.00 - ₹1,916.60
% from 52W High-34.72%-7.12%
All-Time High₹232.90 (Jun 17, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-69.38%-9.19%
Growth Metrics
Quarterly Revenue Growth-0.01%0.14%
Quarterly Earnings Growth0.06%0.16%
Financial Health
Profit Margin (TTM) i0.43%0.19%
Operating Margin (TTM) i0.06%0.26%
Return on Equity (TTM) i0.09%0.15%
Debt to Equity (MRQ) i0.096.68
Cash & Liquidity
Book Value per Share (MRQ)₹63.14₹324.46
Cash per Share (MRQ)N/A₹115.87
Operating Cash Flow (TTM) i₹105.01M₹110.84B
Levered Free Cash Flow (TTM) i₹80.76M₹109.29B
Dividends
Last 12-Month Dividend Yield i4.03%0.97%
Last 12-Month Dividend i₹4.00₹16.50

Valuation & Enterprise Metrics Analysis: Denis Chem Lab Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricDENISCHEM (Apr 26, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i12.2636.73
Forward P/E iN/A29.48
PEG Ratio i0.143.59
Price to Sales (TTM) i0.627.05
Price to Book (MRQ) i1.225.15
Market Capitalization
Market Capitalization i₹1.07B₹3.88T
Enterprise Value i₹1.07B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i0.626.66
Enterprise to EBITDA i5.6123.61
Risk & Other Metrics
Beta iN/A0.11
Book Value per Share (MRQ) i₹63.14₹324.46

Financial Statements Comparison: Denis Chem Lab Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDENISCHEM (2025)SUNPHARMA (2025)
Revenue/Sales i1.73B520.41B
Cost of Goods Sold i981.93M121.98B
COGS % of Revenue i56.7%23.4%
Gross Profit i751.05M398.44B
Gross Margin i43.3%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i103.13M125.81B
Operating Margin i6.0%24.2%
EBITDA i190.23M167.25B
EBITDA Margin i11.0%32.1%
Pre-Tax Income i111.11M137.52B
Pre-Tax Income % of Revenue i6.4%26.4%
Income Tax i30.36M27.72B
Income Tax % of Revenue i1.8%5.3%
Net Income (Profit) i80.76M109.65B
Profit Margin i4.7%21.1%

Balance Sheet & Liquidity Metrics

MetricDENISCHEM (2025)SUNPHARMA (2025)
Cash & Equivalents i8.50M102.69B
Total Current Assets i706.45M526.24B
Total Current Assets % of Revenue i40.8%101.1%
Total Current Liabilities i261.73M181.94B
Total Current Liabilities % of Revenue i15.1%35.0%
Long-Term Debt i4.53M3.58B
Long-Term Debt % of Revenue i0.3%0.7%
Total Shareholders Equity i851.04M724.86B
Retained Earnings i390.31M578.62B
Retained Earnings % of Revenue i22.5%111.2%
Property, Plant & Equipment i39.91M100.36B

Cash Flow Statement Comparison

MetricDENISCHEM (2025)SUNPHARMA (2025)
Operating Cash Flow i105.01M110.84B
Operating Cash Flow % of Revenue i6.1%21.3%
Capital Expenditures iN/A-20.68B
Free Cash Flow i44.64M119.44B
FCF Margin i2.6%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricDENISCHEMSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i13.88M2.40B
Float Shares iN/A1.07B
% Held by Insiders i78.40%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i21.60%15.69%

Dividend Analysis & Yield Comparison: Denis Chem Lab Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricDENISCHEMSUNPHARMA
Last 12-Month Dividend i₹4.00₹16.50
Last 12-Month Dividend Yield i4.03%0.97%
3-Year Avg Annual Dividend i₹3.67₹17.33
3-Year Avg Dividend Yield i1.73%0.51%
3-Year Total Dividends i₹11.00₹52.00
Ex-Dividend DateSep 19, 2025Feb 05, 2026